Shanghai Fosun Pharmaceutical (Group) Co Financial Overview
Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently HK$78.48B. The company's EPS TTM is HK$0.3413536759; its P/E ratio is 17.15; and it has a dividend yield of 1.57%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is HK$0.32. See an overview of income statement, balance sheet, and cash flow financials.
